EVP/Chief Scientific Officer of Editas Medicine Inc (30-Year Financial, Insider Trades) Charles Albright (insider trades) sold 10,000 shares of EDIT on 12/15/2020 at an average price of $63.22 a share. The total sale was $632,200.
Editas Medicine Inc is a genome editing company which is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. Editas Medicine Inc has a market cap of $3.91 billion; its shares were traded at around $62.710000 with and P/S ratio of 40.83. GuruFocus has detected 2 severe warning signs with Editas Medicine Inc. .
Directors and Officers Recent Trades:
- EVP/Chief Scientific Officer Charles Albright sold 10,000 shares of EDIT stock on 12/15/2020 at the average price of $63.22. The price of the stock has decreased by 0.81% since.
- EVP/Chief Scientific Officer Charles Albright sold 10,000 shares of EDIT stock on 12/09/2020 at the average price of $45. The price of the stock has increased by 39.36% since.
- EVP/Chief Scientific Officer Charles Albright sold 20,000 shares of EDIT stock on 12/07/2020 at the average price of $40.02. The price of the stock has increased by 56.7% since.
For the complete insider trading history of EDIT, click here
.
